Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III

  • Petra Kaufmann
  • , John L.P. Thompson
  • , Gilberto Levy
  • , Richard Buchsbaum
  • , Jeremy Shefner
  • , Lisa S. Krivickas
  • , Jonathan Katz
  • , Yvonne Rollins
  • , Richard J. Barohn
  • , Carlayne E. Jackson
  • , Ezgi Tiryaki
  • , Catherine Lomen-Hoerth
  • , Carmel Armon
  • , Rup Tandan
  • , Stacy A. Rudnicki
  • , Kourosh Rezania
  • , Robert Sufit
  • , Alan Pestronk
  • , Steven P. Novella
  • , Terry Heiman-Patterson
  • Edward J. Kasarskis, Erik P. Pioro, Jacqueline Montes, Rachel Arbing, Darleen Vecchio, Alexandra Barsdorf, Hiroshi Mitsumoto, Bruce Levin

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)235-244
Number of pages10
JournalAnnals of Neurology
Volume66
Issue number2
DOIs
StatePublished - Aug 2009
Externally publishedYes

ASJC Scopus Subject Areas

  • Neurology
  • Clinical Neurology

Cite this